Starboard Ditches Effort To Derail Bristol-Myers' $74B Buy

By Chelsea Naso · March 29, 2019, 6:37 PM EDT

Activist hedge fund Starboard on Friday backed away from its campaign to upend Bristol-Myers Squibb's anticipated $74 billion Celgene takeover, hours after two proxy advisory firms came out in support of...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login